The annual Phillip and Ruth Hettleman Prizes for Artistic and Scholarly Achievement have been awarded to four associate professors who exemplify groundbreaking and innovative research.
Fellow, Carolina Population Center
Member, Lineberger Comprehensive Cancer Center
This talk is an expansion of one that Dr. Robinson recorded for an upcoming SER 2021 symposium. That symposium is titled, “What has the pandemic revealed about the shortcomings of modern epidemiology? What can we fix or do better?” In that talk and here, she discusses two shortcomings she perceives in academic epidemiology’s response to the COVID-19 outbreak. One is an overreliance on conditional statistics and the other is workforce that is too homogenous with respect to the diversity of the US population.
Study: Modified immunotherapy may work in advanced breast cancer
By (0)
Researchers say they have found a potential new treatment approach for breast cancer using immunotherapy. File Photo by uschenkova/Shutterstock
Dec. 31 (UPI) Women with advanced breast cancer may have a new weapon in their fight against the disease a modified form of immunotherapy.
CAR-T immunotherapy, in which T cells from a patient s immune system are modified to target cancer cells, has been most effective in the treatment of B-cell leukemia or lymphoma, both of which are cell-based, rather than solid-tumor cancers like breast cancer.
Advertisement
Adding a molecule found in immune cells called cGAMP to standard CAR-T boosts its efficacy in breast cancer by encouraging the body s immune cells to attack solid tumors, according to the authors of a study published Thursday by the Journal of Experimental Medicine.